Abstract
Argatroban possesses strong antithrombin‐like activity. We evaluated the usefulness of argatroban in anticoagulating specimens for routine laboratory tests. Results using blood anticoagulated with argatroban corresponded well with the results of blood treated with ethylendiamine tetra‐acetic acid (EDTA) in the complete blood count (CBC), including the WBC differential count and morphology of blood cells, when the CBC was performed within 2 hr of blood collection. Clinical chemistry results from argatroban‐treated samples were similar to results obtained with serum specimens. Thus, argatroban may be a useful anticoagulant for emergency laboratory medicine. J. Clin. Lab. Anal. 14:136–140, 2000. © 2000 Wiley‐Liss, Inc.
Keywords: argatroban, anticoagulant, ethylendiamine tetra‐acetic acid (EDTA), hematologic tests, chemical tests
REFERENCES
- 1. Okamoto S, Hijikata A, Ikezawa K. 1972. A new series of synthetic thrombin inhibitors (OM‐inhibitors) having extremely potent and selective action. Thromb Res Suppl 8:77–82. [DOI] [PubMed] [Google Scholar]
- 2. Okamoto S, Hijikata A, Kikumoto R. 1979. A synthetic thrombin inhibitor taking extremely active stereostructures. Thromb Haemostas 42:205. [PubMed] [Google Scholar]
- 3. Hijikata A, Okamoto S, Mori E, et al. 1967. In vivo and in vitro studies of a new series of synthetic thrombin inhibitors. Thromb Res 8(Suppl):83–89. [DOI] [PubMed] [Google Scholar]
- 4. Hicks JM. 1999. Excessive blood drawing for laboratory tests. N Engl J Med 340:1690. [DOI] [PubMed] [Google Scholar]
- 5. Okamoto S, Hijikata A, Kikumot R, et al. 1981. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo‐structure of its hydrophobic carboxamide portion. Biochem Biophys Res Commun 101:440–446. [DOI] [PubMed] [Google Scholar]
- 6. Kumada T, Abiko Y. 1981. Comparative study on heparin and a synthetic thrombin inhibitor No. 805 (MD‐805) in experimental antithrombin deficient animals. Thromb Res 24:285–298. [DOI] [PubMed] [Google Scholar]
- 7. Marcie J, Hursting PD, Kenneth LA, et al. 1997. Novastan (brand of argatroban): a small molecule, direct thrombin inhibitor. Semin Thromb Hemost 23:503–516. [DOI] [PubMed] [Google Scholar]
- 8. Nakamura K, Hatano Y, Mori K. 1985. Thrombin‐induced vasoconstriction in isolated cerebral arteries and the influence of a synthetic thrombin inhibitor. Thromb Res 40:715–720. [DOI] [PubMed] [Google Scholar]
- 9. Matsuo T, Koide M, Kario K. 1997. Development of argatroban, a direct thrombin inhibitor, and its clinical application. Semin Thromb Hemost 23:517–522. [DOI] [PubMed] [Google Scholar]
- 10. Tamao Y, Kikumoto R. 1997. Effect of argatroban, a selective thrombin inhibitor, on animal models of cerebral thrombosis. Semin Thromb Hemost 23:523–530. [DOI] [PubMed] [Google Scholar]
- 11. Kobayashi S, Tazaki Y. 1997. Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin Thromb Hemost 23:531–534. [DOI] [PubMed] [Google Scholar]